Clinical trials: Irregular Antibody Screening
Irregular Antibody Screening
Surgiscreen Registration
The purpose of this study is to assess the consistency of the results of irregular antibody screening with Surgiscreen （investigational reagent) and Serascan Diana 3 (control reagent), and the consistency of the results of…
- Trial name
- NCT01589133
- Where
- 4 sites in China
- Volunteers
- 3,109 people
- Sponsor
- Johnson & Johnson Medical, China